The effect of intracameral ketorolac in cataract surgery for diabetic patients

Abstract

Aim: This study aims to assess the effect of intracameral ketorolac interaoperatively in cataract surgery for diabetic patients. Purpose: This study aims to assess the effect of intracameral ketorolac in cataract surgery for diabetic patients. Methods: This study was conducted on cataract patients who need phacoemulsification subjected to ophthalmology department of Menoufia university careful history and ophthalmological examination was done including best corrected visual acuity, slit-lamp examination, fundus examination. All patients were dilated preoperatively by topical tropicamid 1% as mydriatc, and were operated under local peribulbar anesthesia and measurement of pupil diameter by squint caliper at the beginning and at the end of surgery and for standerization systemic and topical NSAIDS were prohibited preoperative. We assed the pupil diameter and surgical time intraoperative Results: The mean pupillary diameter at the end of the operation in first group (non-ketorolac) was 7.18 ± 1.09 mm while in the second (ketorolac) group was 7.98 ± 1.34 mm with p value <0.05 which is statistically significant. On measuring the change that occur to the pupil diameter during surgery in group I it was 1.48 ± 0.77 mean while in group II it was 1.11 ± 0.66 with p value <0.01 which is highly significant also there was significant effect of interacameral ketorolac in decreasing corneal edema. As regard surgical time: In group I the mean surgical time in minutes was 24.73 ± 9.72 while in group II it was 22.77 ± 7.10 which shows that there is decrease in surgical time in ketorolac group but not significant. Conclusion: Intracameral ketorolac is safe in maintaining pupil dilated especially in poorly dilated pupil.